文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

无创通气对腹部手术后低氧性呼吸衰竭患者气管再插管的影响:NIVAS 试验的贝叶斯事后分析

Effect of noninvasive ventilation on tracheal reintubation among patients with hypoxemic respiratory failure following abdominal surgery: a bayesian post-hoc analysis of the NIVAS trial.
PubMed 文献 · Crit Care · 2025-12-10
一句话结论贝叶斯事后分析显示,腹部手术后低氧性呼吸衰竭患者使用无创通气在多种先验假设下均有高概率降低第7天再插管风险。

该研究为 NIVAS 多中心试验的前瞻性注册贝叶斯事后分析,纳入 293 例腹部手术后急性呼吸衰竭患者,随机接受传统氧疗或无创通气。主要终点为第7天再插管,在最小信息先验下后验中位 OR 为 0.59(95% CrI 0.37 至 0.95),支持无创通气;在悲观先验下 OR 为 0.64(95% CrI 0.40 至 1.00)。无创通气优于氧疗的后验概率在不同先验下为 96% 至 99%,绝对风险降低≥5% 的概率为 77% 至 93%。第30天死亡率的后验中位 OR 在最小信息先验下为 0.63(95% CrI 0.32 至 1.31),在怀疑先验下为 0.79(95% CrI 0.48 至 1.29)。作者认为,即使持悲观先验,无创通气也有高概率实现有临床意义的第7天再插管减少,用于腹部手术后呼吸衰竭是合理的。

要点

  • 在最小信息先验下,无创通气降低第7天再插管的后验中位 OR 为 0.59(95% CrI 0.37 至 0.95)。
  • 在悲观先验下,第7天再插管后验中位 OR 为 0.64(95% CrI 0.40 至 1.00)。
  • 无创通气优于氧疗的后验概率在不同先验下为 96% 至 99%。
  • 绝对风险降低≥5% 的后验概率为 77% 至 93%。
  • 第30天死亡率后验中位 OR 在最小信息先验下为 0.63(95% CrI 0.32 至 1.31),在怀疑先验下为 0.79(95% CrI 0.48 至 1.29),无创通气优效概率为 82% 至 90%。

适用人群与场景

  • 腹部手术后发生急性呼吸衰竭的患者,共 293 例,随机接受传统氧疗或无创通气。

研究设计与关键结果

  • 研究类型为 NIVAS 多中心试验的前瞻性注册贝叶斯事后分析,纳入 293 例腹部手术后急性呼吸衰竭患者,随机分为传统氧疗组和无创通气组。
  • 主要终点第7天再插管:最小信息先验下后验中位 OR 为 0.59(95% CrI 0.37 至 0.95),支持无创通气;悲观先验下后验中位 OR 为 0.64(95% CrI 0.40 至 1.00)。
  • 无创通气优于氧疗的后验概率在不同先验下为 96% 至 99%(从悲观先验到热情先验)。
  • 绝对风险降低≥5% 的后验概率为 77% 至 93%。
  • 次要终点第30天死亡率:最小信息先验下后验中位 OR 为 0.63(95% CrI 0.32 至 1.31),怀疑先验下为 0.79(95% CrI 0.48 至 1.29);无创通气优效的后验概率为 82% 至 90%。

证据类型、等级与局限

  • 证据类型为多中心随机对照试验的贝叶斯事后分析;原文未报告证据等级或推荐强度。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,即使持悲观先验,无创通气也有高概率实现有临床意义的第7天再插管减少;作者建议,使用无创通气治疗腹部手术后呼吸衰竭是合理的。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Clinicians’ decision-making regarding the use of noninvasive ventilation (NIV) after abdominal surgery requires evaluating the probability of a clinically meaningful benefit. The Bayesian framework may help caregivers interpret the findings of a randomized controlled trial (NIVAS) assessing curative NIV after abdominal surgery by incorporating their prior beliefs, yielding more precise estimates of treatment effects. This study aimed to use a Bayesian framework to estimate posterior probabilities of NIV effect under various prior assumptions, reflecting diverse clinicians’ beliefs. METHOD: A prospectively registered, post-hoc Bayesian reanalysis of the NIVAS multicenter trial was conducted. The study included 293 patients with acute respiratory failure following abdominal surgery who were randomly assigned to receive either conventional oxygen therapy or NIV. Four statistical priors were defined: minimally informative, skeptical, enthusiastic, and pessimistic, reflecting a range of clinical beliefs. The primary outcome was day-7 reintubation. Secondary outcomes included day-30 mortality. Effect sizes were presented as odds ratios (OR) and absolute risk reduction (ARR) with 95% credible intervals (CrI). RESULTS: The minimally informative prior resulted in a posterior median OR for day-7 reintubation of 0.59 (95% CrI 0.37 to 0.95) in favor of NIV. Under the pessimistic prior, the posterior median OR was 0.64 (95% CrI 0.40 to 1.00). The posterior probability that NIV is superior to oxygen therapy varied from 96 to 99% across various priors, from pessimistic to enthusiastic. The probability of benefit beyond an ARR ≥ 5% ranged from 77 to 93%. Regarding day-30 mortality, the posterior median OR was 0.63 (95% CrI 0.32 to 1.31) under minimally informative prior and 0.79 (95% CrI 0.48 to 1.29) under the skeptical prior. The probability of NIV superiority ranged from 82 to 90%. CONCLUSION: This Bayesian trial re-analysis indicates that NIV has a high probability of achieving a clinically meaningful reduction in day 7 reintubation, even under pessimistic prior beliefs. These results suggest that use of NIV to treat respiratory failure after abdominal surgery is reasonable.

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. Naudet-Lasserre A, Pensier J, de Jong A, et al. Effect of noninvasive ventilation on tracheal reintubation among patients with hypoxemic respiratory failure following abdominal surgery: a bayesian post-hoc analysis of the NIVAS trial. Crit Care. 2025. PMID: 41372778. doi:10.1186/s13054-025-05795-9

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。